NRX Pharmaceuticals, Inc. Stock Issued During Period, Shares, Issued for Services
NRX Pharmaceuticals, Inc. (NRXP) had Stock Issued During Period, Shares, Issued for Services of 218.16 thousand shares as of 2026-05-31, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2026-08-14
- 2026-05-31: Stock Issued During Period, Shares, Issued for Services 218.16K shares.
- 2025-07-17: Stock Issued During Period, Shares, Issued for Services 150.00K shares.
- 2024-08-28: Stock Issued During Period, Shares, Issued for Services 20.00K shares.
| Period end | Stock Issued During Period, Shares, Issued for Services |
|---|---|
| 2026-05-31 | 218.16K shares 10-Q · filed 2026-08-14 |
| 2025-07-17 | 150.00K shares 10-K · filed 2026-03-23 |
| 2024-08-28 | 20.00K shares 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |